Phase 2 Readout
GNLX: Phase 2 Readout: olvi-vec
December 31, 2026 · olvi-vec. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- GENELUX Corp (GNLX)
- Drug
- olvi-vec
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: olvi-vec
- Company
- GENELUX Corp (GNLX)
- Drug
- olvi-vec
- Indication
- VIRO-25 trial